Utilizing an automated cloud-based platform, Palantine Foundry, to generate and build large databases for clinical research applications.
165 Background: Academic institutions are adopting automated tools to help develop and maintain large databases. Leveraging advances in clinical data warehouses and artificial intelligence can potentially decrease resource utilization and the time required to conduct research by reducing intensive manual human curation of data. Methods: This research was performed as part of the institutional Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE), IRB-approved protocol 2020-0348. Data were obtained from both structured and unstructured data sources within the MD Anderson electronic health record to validate a retrospective analysis for COVID-19 positive patients undergoing radiation treatments. Multiple data sources were identified, integrated and analyzed using the Syntropy Foundry platform, part of the Context Engine Data Management System at M.D. Anderson Cancer Center (MDACC) to include patient demographics, clinical notes, laboratory values, radiology reports, and oncology treatments. The platform allows real-time updating of these data-sources with integrated statistical packages to streamline rapid statistical analyses. We conducted a retrospective review of patients treated within 3 weeks of COVID infection between March 2020 and November 2022. Patient data was obtained using Foundry. Patients who tested positive for COVID-19 and had their treatment postponed were categorized as having a treatment delay. Patients who started radiation therapy and subsequently had an interruption in treatment due to contracting COVID-19 were categorized as having a treatment break. The Kaplan-Meier method was used to compare survival outcomes and was conducted within Foundry. Results: Syntropy Foundry helped develop a database comprising of 380 COVID-19 positive patients treated with radiation therapy between March 2020 through November 2022. It validated patient demographic information and research variables including patient age, histology, cancer stage, treatment plans, radiographic scans, recurrences, and follow up time that were separately performed manually. It reduced the time and human resources required to retrospectively collect and review these patient charts. Conclusions: Syntropy Foundry and ongoing efforts to leverage machine learning models to facilitate the interpretation of the large amount of accessible clinical data can potentially improve quality and reduce resources needed to generate large research databases. Future applications using artificial intelligence with Foundry to identify clinical recurrence and report patient outcome are under development.
Authors
- Paul Edelkamp (ORCID: https://orcid.org/0000-0001-5881-8292)
- Scott E. Woodman (ORCID: https://orcid.org/0000-0002-1157-6991)
- Quynh Nguyen (ORCID: https://orcid.org/0000-0001-8466-7643)
- Julius Weng (ORCID: https://orcid.org/0000-0002-7064-6865)
- David C. Qian (ORCID: https://orcid.org/0000-0002-8459-009X)
- Mark Knafl (ORCID: https://orcid.org/0000-0002-3953-2173)
- Zhongxing Liao (ORCID: https://orcid.org/0000-0002-2224-9478)
- Paul Roy
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-08-10
- DOI
- https://doi.org/10.1200/jco.2024.42.23_suppl.165
- Primary Topic
- Scientific Computing and Data Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00